Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
WINT Windtree Therapeutics Inc	$47.8M	$0 0.0% of portfolio	0	Q4 2024 New
XFOR X4 Pharmaceuticals, Inc	$17.2M	$0 0.0% of portfolio	0	Q4 2024 New
XBIT X Biotech Inc.	$94.4M	$0 0.0% of portfolio	0	Q4 2024 New
XNCR Xencor Inc	$670M	$0 0.0% of portfolio	0	Q4 2024 New
XERS Xeris Biopharma Holdings, Inc.	$759M	$0 0.0% of portfolio	0	Q4 2024 New
XLO Xilio Therapeutics, Inc.	$20.6M	$0 0.0% of portfolio	0	Q4 2024 New
XOMA Xoma Corp	$233M	$0 0.0% of portfolio	0	Q4 2024 New
XTLB Xtl Biopharmaceuticals LTD	$6.92M	$0 0.0% of portfolio	0	Q4 2024 New
YMAB Y M Abs Therapeutics, Inc.	$210M	$0 0.0% of portfolio	0	Q4 2024 New
ZLAB Zai Lab LTD	$3.65B	$0 0.0% of portfolio	0	Q4 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$103M	$0 0.0% of portfolio	100	Q2 2022 New
TSVT 2seventy Bio, Inc.	$187M	$0 0.0% of portfolio	0	Q4 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$118M	$0 0.0% of portfolio	0	Q4 2024 New
ETNB 89bio, Inc.	$376M	$0 0.0% of portfolio	0	Q4 2024 New
AADI Aadi Bioscience, Inc.	$40.1M	$0 0.0% of portfolio	0	Q4 2024 New
ABCL Ab Cellera Biologics Inc.	$659M	$0 0.0% of portfolio	0	Q4 2024 New
ABEO Abeona Therapeutics Inc.	$29.6M	$0 0.0% of portfolio	0	Q4 2024 New
ABSI Absci Corp	$251M	$0 0.0% of portfolio	0	Q4 2024 New
ACIU Ac Immune Sa	$165M	$0 0.0% of portfolio	0	Q4 2024 New
ACAD Acadia Pharmaceuticals Inc	$2.76B	$0 0.0% of portfolio	0	Q4 2024 New
ACHL Achilles Therapeutics PLC	$60.3M	$0 0.0% of portfolio	0	Q4 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$45.6M	$0 0.0% of portfolio	0	Q4 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$48.2M	$0 0.0% of portfolio	0	Q4 2024 New
ACXP Acurx Pharmaceuticals, Inc.	$4.51M	$0 0.0% of portfolio	0	Q4 2024 New
ADAG Adagene Inc.	$67.7M	$0 0.0% of portfolio	0	Q4 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	0	Q4 2024 New
ADAP Adaptimmune Therapeutics PLC	$34.3M	$0 0.0% of portfolio	0	Q4 2024 New
ADPT Adaptive Biotechnologies Corp	$1.1B	$0 0.0% of portfolio	0	Q4 2024 New
ADCT Adc Therapeutics Sa	$116M	$0 0.0% of portfolio	0	Q4 2024 New
ACET Adicet Bio, Inc.	$33.2M	$0 0.0% of portfolio	0	Q4 2024 New
ADMA Adma Biologics, Inc.	$3.98B	$0 0.0% of portfolio	0	Q4 2024 New
AVTE Aerovate Therapeutics, Inc.	$61.9M	$0 0.0% of portfolio	0	Q4 2024 New
AGIO Agios Pharmaceuticals, Inc.	$1.66B	$0 0.0% of portfolio	0	Q4 2024 New
AIKI A Ikido Pharma Inc.	$20.8M	$0 0.0% of portfolio	0	Q4 2024 New
AIM Aim Immuno Tech Inc.	$5.77M	$0 0.0% of portfolio	0	Q4 2024 New
AKBA Akebia Therapeutics, Inc.	$351M	$0 0.0% of portfolio	0	Q4 2024 New
AKRO Akero Therapeutics, Inc.	$1.98B	$0 0.0% of portfolio	0	Q4 2024 New
ALBO Albireo Pharma, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
ALDX Aldeyra Therapeutics, Inc.	$389M	$0 0.0% of portfolio	0	Q4 2024 New
ALEC Alector, Inc.	$107M	$0 0.0% of portfolio	0	Q4 2024 New
ALLK Allakos Inc.	$20.3M	$0 0.0% of portfolio	0	Q4 2024 New
ALLR Allarity Therapeutics, Inc.	$10.7M	$0 0.0% of portfolio	0	Q4 2024 New
ALLO Allogene Therapeutics, Inc.	$223M	$0 0.0% of portfolio	0	Q4 2024 New
ALVR Allovir, Inc.	$913M	$0 0.0% of portfolio	0	Q4 2024 New
DRTS Alpha Tau Medical Ltd.	$177M	$0 0.0% of portfolio	0	Q4 2024 New
ATHE Alterity Therapeutics LTD	$138M	$0 0.0% of portfolio	0	Q4 2024 New
ALT Altimmune, Inc.	$261M	$0 0.0% of portfolio	100	Q2 2023 New
ALXO Alx Oncology Holdings Inc	$26.9M	$0 0.0% of portfolio	0	Q4 2024 New
FOLD Amicus Therapeutics, Inc.	$2.36B	$0 0.0% of portfolio	0	Q4 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$214M	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.